Details of the Drug Reposition

General Information of This Drug (ID: DMWKYSM)

• Drug Name: Anti-CD19-CAR (DMWKYSM)
• Drug Type: CAR T Cell Therapy

Information on Drug Reposition of This Drug

5 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
leukaemia	DISS7D1V	2A60-2B33	Phase 1	[1]
Large cell lymphoma	DISYZHCP	2A80.Z	Phase 1	[1]
Acute lymphoblastic leukaemia	DIS87TGM	2A85	Phase 1	[1]
B-cell lymphoma	DISIH1YQ	2A86	Phase 1	[1]
Non-hodgkin lymphoma	DISS2Y8A	2B33.5	Phase 1	[1]

References

• [1] ClinicalTrials.gov (NCT01593696) Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma